Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic


News provided by

Fosun

Jan 31, 2023, 02:45 ET

Share this article

Share toX

Share this article

Share toX

HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun Foundation announced on 9 January 2023 the cooperation with Fosun Pharma and Genuine Biotech to donate RMB100 million worth of Azvudine tablets, the oral medication for COVID-19, helping the grassroots to weather the epidemic. As of 29 January 2023, under the campaign of "A Healthy Winter Action", a total of 173,200 bottles of Azvudine tablets have been donated to 116 counties in 19 provinces, municipalities, and autonomous regions, including Yunnan, Tibet, Xinjiang, Hainan, Anhui, Jiangxi, Ningxia, Sichuan, Chongqing, and Heilongjiang. Azvudine tablets, the first domestically developed small molecule medication for COVID-19 has helped at least 150,000 villagers get through the epidemic more safely, most of whom were seniors over 65.

Since its inception, "A Healthy Winter Action" has faced two major challenges. First, how to deliver materials to the grassroots during the peak-travel period of Spring Festival? Second, how to accurately distribute medicines to the villagers who are in need of medicine?

While negotiating cooperation with SF Express, Fosun Foundation urgently recruited nearly a hundred employee volunteers within Fosun and its subsidiaries. Coordinating with their plan of returning home during the Spring Festival, the volunteers personally delivered medication to the donated counties.

In addition to Fosun employee volunteers, SF Express also fully supported the donation. The delivery of medication did not stop during the Spring Festival. Guo Shuai, Assistant Secretary-General and Project Director of Fosun Foundation, stayed in the office throughout the Spring Festival to make sure that the materials are dispatched to SF Express's transshipment warehouse immediately, and then delivered by air.

How to make sure that the most urgently needed villagers can receive medication in time? According to Ning Guang, Consultant of the COVID-19 Prevention and Control Expert Committee of the Rural Doctors Program and President of Ruijin Hospital affiliated with Shanghai Jiaotong University School of Medicine, "Rural doctors must have medicine in their hands, and the grassroots people must receive medicine in time". Fosun Foundation first covered the 72 counties in the Rural Doctors Program which has been running for five years, and delivered as much medicine as possible to rural doctors through the health department before the Spring Festival.

On 16 January, the first batch of 600 bottles of Azvudine tablets donated to Lancang County, Yunnan Province was delivered by Zhao Zhong, a resident member of the Rural Doctors Program, to the township hospital of Lancang County, and then to the village clinics. Zhong Liping, a rural doctor in Yanyin Village, Sakai Township, received a message from villager Zhong Asuo on the morning of the fifth day of the Chinese New Year, "Thank you for the Azvudine tablets sent by Fosun Foundation before Chinese New Year. My father felt much better the next day after taking the medicine." Before taking Azvudine tablets, Zhong Asuo's 87-year-old father had fever, cough and other symptoms. When she learned that Fosun Foundation had donated to Lancang County, Zhong Liping immediately thought of distributing medicine to the elderly. Zhong Liping said, "It is this kind of feedback that makes me realize the importance of being a rural doctor."

In order to improve the diagnostic skills of rural doctors, Fosun Foundation and Shanghai Guangci Translational Medical Research Foundation jointly established an expert committee led by Chen Erzhen, Vice President of Ruijin Hospital. Medical experts from more than 20 provinces provided targeted training for rural doctors in the form of recorded courses and Q&A sessions. Relevant training has been launched on the app of Fosun Health and People's Good Doctor. So far, more than 15,000 rural doctors have received the training online. On 13 January, with the organization of the Guizhou Provincial Health Commission and Fosun Foundation, Zhang Wenhong, a member of the expert committee, Director of the National Medical Center for Infectious Diseases, and Professor of Huashan Hospital affiliated to Fudan University, conducted a special online training for rural doctors in Guizhou.

Along with the medicine, 37 care packages worth RMB150,000 were sent to the grassroots, which contained medical supplies that were in short supply at the grassroots, such as oximeters, oxygen concentrators, face masks, and nitrile gloves. These packages were donated by public welfare partners including Industrial and Commercial Bank of China, the New Social Stratum "New Philanthropy Program" under the United Front Work Department of CPC Central Committee, Shanghai Pudong Development (Group) Co., Ltd., Taiping Pension Co., Ltd., YouChange China Social Entrepreneur Foundation, Pingdingshan Volunteers Association, Chengdu Charity Federation, S.F. Express Group (Shanghai) Co., Ltd., Yeswood, Wuxi Qicheng Industrial Co., Ltd., Institute of Innovations, Tongxinhui, Xinjiang Juchen Law Firm, Jiangsu No. 33 Business Management Co., Ltd., Wuxi Yushou Medical Appliances Co., Ltd., Shanghai Tuyue Business Advisory Co., Ltd., Power Construction Corporation of China, and Shanghai Charity Foundation Xuhui District Representative Office Ningguo Temple 456 Cultural Special Fund, and benevolent enterprises of ONE Fosun such as Shede Spirits, Jinhui Liquor, Hainan Mining, and Golte.

In addition, in order to strengthen the digital capability of primary healthcare institutions, Shanghai Aitrox Technology Co. Ltd., a subsidiary of Fosun, donated digital imaging systems, digital ultrasound systems and refined operation services to primary township hospitals, covering 10 township hospitals by the end of April this year, with the first batch of donations amounting to approximately RMB5 million.

On 28 January 2023, the first day of work, the project team resumed regular meetings twice a day. At the regular meeting that night, Chen Qiyu, Co-CEO of Fosun International, said, "We have completed half of the RMB100 million medicine donation, and reached 2/3 of the goal of donating to 180 counties. We must continue to race against the virus and prepare for the next wave of infection peaks. For example, we must cover at least another 20 counties in the Tibet Autonomous Region; we must focus on protecting the elderly in cities below the third tier and in rural nursing homes. The donation of about 400,000 bottles of Azvudine tablets worth RMB100 million jointly initiated by Fosun and Genuine Biotech has been considered to be the largest public welfare donation of medicine in recent years. We hope play its due role in the revitalization of Chinese rural areas and the construction of a healthy China."

SOURCE Fosun

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Fosun International Achieves AA- in HSI ESG Rating for Third Consecutive Year, Marks Sixth Year as Constituent of Hang Seng Corporate Sustainability Benchmark Index

On 9 September 2025, Fosun International Limited (HKEX stock code: 00656, hereinafter referred to as "Fosun International" or the "Company") was...

Fosun International Recognized among Fortune's 2025 "Most Admired Chinese Companies" List

On 9 September, Fortune China magazine released its 2025 list of "Most Admired Chinese Companies", in which Fosun International Limited ("Fosun...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.